Biogen Selects Veeva Vault CRM
Aug 25, 2026
Healthcare
EY Acquires Aqurance to Expand Veeva Technology Services for Life Sciences
Oct 13, 2025
EY has acquired Greece-based Veeva services partner Aqurance to strengthen its Veeva Centers of Excellence and expand clinical, regulatory, and commercial capabilities for global life sciences clients.
EY has acquired Greek Veeva services partner Aqurance to enhance its Veeva Centers of Excellence and expand its clinical, regulatory, and commercial service capabilities for life sciences companies, announced in a press release.
Aqurance, a recognized Veeva Premier Services Partner for Commercial Cloud and Services Partner for Development Cloud, provides consulting across Veeva applications used in both commercial and R&D operations. The acquisition will combine EY’s regulatory, business design, and technology integration expertise with Aqurance’s experience in Veeva Vault and related applications.
The integration aims to help pharmaceutical and biotech clients improve efficiency and compliance through unified Veeva platforms, supporting transitions to Vault CRM and broader digital transformation. EY stated that the combined capabilities will enable life sciences organizations to use data and AI more effectively across their operations.
Following the acquisition, EY Aqurance will participate as a platinum sponsor at the Veeva Commercial Summit in Madrid on November 5–6, 2025.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Funding
Sep 22 Ande Raises More Than $52 Million for Corporate Entertainment Platform Sep 22 xtraCHEF Founders Launch Tandem for Restaurant Operations Sep 22 Nexstrom Raises $12 Million for 12 Inch Semiconductor Wafer Platform Sep 22 Sela AI Raises $21 Million for Mortgage Voice Agents Sep 22 Baselayer Raises $35 Million and Launches Identity Suite for AI AgentsMore from Life Sciences
Sep 22 Aqurio Named Finalist for 2026 AI Startup of the Year Sep 22 Tsingke Introduces Validation Workflow for AI Designed Proteins Sep 22 QC Healthcare Partners With Sanguina for AI Blood Health Screening Sep 22 RIVANNA Files 100th Patent for Ultrasound AI Sep 22 Ultima Genomics Platform Selected for Precure's One Million Sample DatasetFree newsletter
AI Funding Brief
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
The Hackett Group
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Amgen Selects Veeva Vault CRM for Global Deployment
Sep 16, 2026
Life Sciences
Regeneron Selects Veeva Vault CRM Globally
Aug 25, 2026
Healthcare
Enovis Makes Binding Offer to Acquire eCential Robotics
Sep 01, 2026
Acquisitions
Envestnet to Acquire Vestmark for Trading and AI Tools
Sep 09, 2026
Acquisitions
MRO Acquires Vyne Medical to Expand Clinical Data Platform
Sep 16, 2026
Acquisitions
Free, six days a week
Daily AI Brief: the AI news that matters, in your inbox.